Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 16 - Number 8
Editorial Open Access
Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)
, 16(8): 651Maria Bozko, Monika Podhorecka, Arkadiusz Macheta, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
DOI: 10.2174/156800961608160902101746
Review Article
Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
, 16(8): 652 - 658Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko
DOI: 10.2174/1568009616666160427103930
Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
Review Article
Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
, 16(8): 659 - 668Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei
DOI: 10.2174/1568009616666160809102219
Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Review Article
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
, 16(8): 669 - 688Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak
DOI: 10.2174/1568009616666160408145623
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
Review Article
Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia
, 16(8): 689 - 700John C. Riches and John G. Gribben
DOI: 10.2174/1568009616666160408145741
Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia
Review Article
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
, 16(8): 701 - 709Lukas Smolej
DOI: 10.2174/1568009616666160408150032
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Review Article
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
, 16(8): 710 - 720Lukas Smolej
DOI: 10.2174/1568009616666160408145850
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Research Article
Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma
, 16(8): 721 - 736Kubra Karagoz, Heather L. Lehman, Douglas B. Stairs, Raghu Sinha and Kazim Y. Arga
DOI: 10.2174/1568009616666160203113721
Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net